Corrigendum to: A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 29, 2022
Source ID
10.1093/neuonc/noac181

Entities

Organizations

  • National Cancer Institute
  • National Institutes of Health
  • United States Department of Defense